Medical platform Doximity's disappointing guidance overshadowed a strong quarterly report. Nonetheless, two analysts raised revenue outlooks.

SaaS Stocks Aren't Out of the Woods Just Yet

08:35am, Wednesday, 17'th May 2023
Stock markets looked poised to recover some of their recent losses on Wednesday morning. Wix.com shares moved higher as the website facilitator lauded its AI efforts.
Doximity, Inc. (NYSE:DOCS ) Q4 2023 Earnings Conference Call May 16, 2023 5:00 PM ET Company Participants Perry Gold - Head, IR Jeffrey Tangney - Co-Founder and CEO Anna Bryson - CFO Nate Gross - Co-F
Doximity (DOCS) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.21 per share a year ago.

3 Best Stocks to Buy in May and Hold Forever

07:45am, Wednesday, 10'th May 2023
Teladoc looks to transition from a high-flying growth story to a profitable enterprise. Doximity's early profitability and cash generation point to incredible potential ahead.

The Top 3 Artificial Intelligence Stocks to Watch

11:06am, Thursday, 20'th Apr 2023
Since ChatGPT was released last November, artificial intelligence stocks have become all the rage. As a result, every media company engaged with consumers had to have its own Chatbot.
Investors interested in Medical Services stocks are likely familiar with Elevance Health (ELV) and Doximity (DOCS). But which of these two stocks presents investors with the better value opportunity r
ELV vs. DOCS: Which Stock Is the Better Value Option?
Soaring interest rates have shares of the best and worst growth stocks under a lot of pressure. SoFi Technologies is a digital bank that trades below its book value even though it's growing by leaps a

Could AI Supercharge This Growth Stock?

02:00pm, Saturday, 11'th Mar 2023
Doximity is testing an AI tool that could save doctors a lot of time. The healthcare company already is a favorite of doctors, with more than 80% of them using the platform.
Doximity's ability to connect physicians with pharmaceuticals and health systems is a wildly prosperous pairing. Medpace's customers could struggle in 2023, but its long-term opportunity will only gro

2 Beaten-Down Growth Stocks to Buy on the Dip

05:48am, Tuesday, 07'th Mar 2023
Some of the growth stocks that were beaten mercilessly in 2022 are still trading at sensible valuations. Doximity is a social media platform viewed regularly by roughly 80% of America's physicians.

Doximity Stock: Bear vs. Bull

05:30am, Monday, 06'th Mar 2023
Doximity's earnings have climbed as it attracts more users and advertisers. But the share performance hasn't reflected the company's successes.

Doximity Stock: Bull vs. Bear

05:55am, Friday, 03'rd Mar 2023
Investors haven't had any reasons to be bullish about the stock in a long time. Do they now?

Doximity Is Getting In on the ChatGPT Hype

09:53am, Wednesday, 01'st Mar 2023
Does this make Doximity a no-brainer buy?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE